Request Demo
Last update 29 May 2025
Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical Co., Ltd.
Private Company | Subsidiary Company|2014|Liaoning Sheng, China
Private Company | Subsidiary Company|2014|Liaoning Sheng, China
Last update 29 May 2025
Overview
Tags
Neoplasms
Hemic and Lymphatic Diseases
Skin and Musculoskeletal Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20233920
评价XZ120在恶性肿瘤患者中的安全性、耐受性、药代动力学特征及初步有效性的Ⅰ期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary efficacy of XZ120 in patients with malignant tumors
CTR20231425
SPH4336联合内分泌治疗伴脑转移的HR阳性、HER2阴性转移性乳腺癌的Ⅱ期临床研究
[Translation] Phase II clinical study of SPH4336 combined with endocrine therapy for HR-positive, HER2-negative metastatic breast cancer with brain metastases
CTR20231256
SPH4336联合内分泌治疗既往经CDK4/6抑制剂联合内分泌治疗进展的HR阳性、HER2阴性局部晚期或转移性乳腺癌的II/III期临床研究
[Translation] A phase II/III clinical study of SPH4336 combined with endocrine therapy for HR-positive, HER2-negative locally advanced or metastatic breast cancer that has progressed on CDK4/6 inhibitor combined with endocrine therapy
100 Clinical Results associated with Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Pharmaceutical Group (Benxi) North Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 08 Jul 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
IND Approval
1
1
Phase 1
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free